The Food and Drug Administration approved Eraxis (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems.
The Food and Drug Administration (FDA) approved Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase, giving American consumers an additional, lower cost alternative when choosing prescription drug products.
The Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression.
To minimize microbial food safety hazards common to the processing of most fresh-cut fruits and vegetables sold to consumers in a ready-to-eat form, The Food and Drug Administration (FDA) published a draft guidance document for producers of fresh-cut produce entitled “Guide to Minimize Microbial Food Safety Hazards of Fresh-cut Fruits and Vegetables.”
Once you have made up your mind to lose weight, you should make the commitment and go into it with a positive attitude. We all know that losing weight can be quite a challenge. In fact, for some, it can be downright tough. It takes time, practice and support to change lifetime habits. But it’s a process you must learn in order to succeed. You and you alone are the one who has the power to lose unwanted pounds.
The Food and Drug Administration (FDA), the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Medicare & Medicaid Services (CMS) today announced the Oncology Biomarker Qualification Initiative (OBQI) — an agreement to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation.
A very commonly seen problem in the clinic for which parents seek treatment and get concerned out of proportion. Children vary in the age at which they gain nocturnal continence of urine. About 10-15% of normal children at the age of 5 years still wet the bed at night. Boys slightly predominate over girls (as girls generally attain nocturnal bladder control early than boys), and there is increased incidence in some families. The factors leading to gaining in the bladder control are complex and involve maturation of the necessary neurological pathways as well as emotional factors.
Treatments for carpal tunnel syndrome should begin as early as possible, under a doctor’s direction. Underlying causes such as diabetes or arthritis should be treated first.
Hair is a striking feature of human body. Hair loss, especially by female/male pattern baldness is matter of great concern. Pattern baldness is particularly is very troubling condition. In this type of baldness the hair is regularly lost at both the temples and at top of the skull. At last the person is left with a horseshoe pattern in the head.
Androgenetic alopecia (male and female pattern balding) is by far the most common cause of hair loss amongst men and a serious problem for many women. There are three important components which are responsible for both female and male balding: